Women Infertility – Pipeline by Competitor Information, Analysis, and Insights to Formulate Effective R&D Strategies 2017

WiseGuyReports.com adds Exclusive Research on “Women Infertility” reports to its database.

PUNE, INDIA - October 13, 2017 /MarketersMedia/ —

SUMMARY

WiseGuyReports published new report, titled “Women Infertility - Pipeline Review, H2”

Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2017, provides an overview of the Women Infertility (Women's Health) pipeline landscape.
Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and endometriosis. Symptoms include abnormal periods, weight gain, back pain, pelvic pain, and cramping. Risk factor of infertility includes smoking tobacco, using alcohol, being overweight, being exposed to toxins, certain medical conditions, including tumors and chronic illnesses. Treatment includes medications to stimulate ovulation and hormone therapies.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385306-women-infertility-pipeline-review-h2-2017

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Women Infertility - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Women Infertility (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Women Infertility (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Women Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 7, 16, 14, 1, 22, 9 and 5 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 2, 5 and 3 molecules, respectively.
Women Infertility (Women's Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Women Infertility (Women's Health).
- The pipeline guide reviews pipeline therapeutics for Women Infertility (Women's Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Women Infertility (Women's Health) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Women Infertility (Women's Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Women Infertility (Women's Health)

Key points to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Women Infertility (Women's Health).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Women Infertility (Women's Health) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents
Introduction
Women Infertility - Overview
Women Infertility - Therapeutics Development
Women Infertility - Therapeutics Assessment
Women Infertility - Companies Involved in Therapeutics Development
Women Infertility - Drug Profiles
Women Infertility - Dormant Projects
Women Infertility - Discontinued Products

..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: wiseguyreports
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +44 208 133 9349

Source URL: https://marketersmedia.com/women-infertility-pipeline-by-competitor-information-analysis-and-insights-to-formulate-effective-rd-strategies-2017/249960

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 249960

Latest News

The Latest: UN chief condemns attack on Afghan vote center

Apr 24, 2018

KABUL, Afghanistan — The Latest on the violence in Afghanistan (all times local): 6 a.m. U.N. Secretary-General Antonio Guterres has condemned the attack on a voter registration center in Afghanistan. The suicide bombing in Kabul on Sunday killed at least 57 people with more than 100 wounded. The Islamic State group claimed responsibility, saying it targeted Shiite "apostates." Guterres said the culprits must be brought to justice. "They must not be allowed to succeed in deterring Afghan citizens from carrying out their constitutional right to take part in forthcoming elections." He extended condolences to the families and expressed solidarity with...

Nepal honors 1st conquest of Everest without bottled oxygen

Apr 24, 2018

KATHMANDU, Nepal — Nepal's government on Thursday honored two climbers who were the first to scale Mount Everest without supplementary oxygen 40 years ago. Minister for Tourism Rabindra Adhikari praised the climbers at a ceremony in the capital, Kathmandu. Italian Reinhold Messner and Austrian Peter Habeler reached the summit without use of supplementary oxygen, while others on their team used bottled oxygen. Until then, all climbers carried oxygen cylinders to aid them at high altitudes where oxygen levels are low. Since Everest was first scaled in 1953, thousands of climbers have reached the summit and hundreds more make attempts every...

Iran bans government bodies from using foreign message apps

Apr 24, 2018

TEHRAN, Iran — Iran's presidency has banned all government bodies from using foreign-based messaging apps to communicate with citizens, state media reported Wednesday, after economic protests organized through such apps shook the country earlier this year. Chief among those apps is Telegram, used by over 40 million Iranians for everything from benign conversations to commerce and political campaigning. Iranians using Telegram, which describes itself as an encrypted message service, helped spread the word about the protests in December and January. Telegram channels run on behalf of Iran's Supreme Leader, Ayatollah Ali Khamenei, and Vice President Eshaq Jahangiri were already shut...

Sherpa guide trying to reach top of the world for 22nd time

Apr 24, 2018

KATHMANDU, Nepal — Three men have climbed to the top of the world 21 times, all of them mountain guides who grew up in the shadow of Mount Everest. Two of these famed Sherpa guides have retired. But 48-year-old Kami Rita says he'll be summiting Everest for years to come. "My goal is to reach the summit of Everest at least 25 times," he told The Associated Press in Kathmandu, Nepal's capital, shortly before heading back to the mountain for what he hopes will mark a record-breaking climb. "I want to set a new record not just for myself but...

23 children die in India when school bus plunges into gorge

Apr 24, 2018

NURPUR, India — A school bus plunged off a mountain road Monday into a deep gorge in the Himalayan foothills, killing 23 children, some as young as 4, Indian officials said. Four adults also died, said Sandeep Kumar, a local official. Ten children were hospitalized. Initial reports indicated the bus driver was speeding as he took the children home and lost control at the edge of the gorge. The bus fell some 200 feet (60 meters) to the ground below, said police officer Sunil Kumar. The adults killed included the bus driver, two teachers and another woman, officials said. Most...

Search
Broaden News

Sign up now!

Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Contact us: sales[at]recentdiscovery.com